Enabling Precision Medicine in Oncology, CNS & NASH to Power Advanced, Affordable Diagnostics for All
Event Dates
2023-04-26 - 2023-04-27
Organizer
Website
Exhibitors
30
Floor Size
0
Attendees
250
Event contact title
Contact
Event contact first name
.
Event contact last name
.
Email
info@hansonwade.com
Event contact telephone number
+44 (0)20 3141 8700
Description
The 13th Clinical Biomarkers & CDx Europe 2023 returns as the premier European forum for end-to-end discussions, actionable insights and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress towards commercialisation.
With two dedicated tracks on Biomarker Development and Drug-Dx Development & Commercialisation, this summit will be your ultimate guide to:
- Understand European Biomarkers & CDx Development advancements in multiple disease areas in oncology and non-oncology indications
- Discuss emerging functional assays and software technologies to advance and accelerate clinical and research programs aimed at personalising care for patients
- Stay up to date with European specific regulatory, commercialisation and market access challenges and processes to successfully create your end-to-end biomarker & CDx strategy
- Join forces to define a better framework for reimbursement of biomarkers that enable an equitable access to them for patients